Stass SA - Search Results

1

Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia.

Verschraegen CF, Talpaz M, Hirsch-Ginsberg CF, Pherwani R, Rios MB, Stass SA, Kantarjian HM. Verschraegen CF, et al. Among authors: stass sa. Blood. 1995 May 15;85(10):2705-10. Blood. 1995. PMID: 7742530 Free article.

2

Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia.

Claxton D, Deisseroth A, Talpaz M, Reading C, Kantarjian H, Trujillo J, Stass S, Gooch G, Spitzer G. Claxton D, et al. Blood. 1992 Feb 15;79(4):997-1002. Blood. 1992. PMID: 1371081 Free article.

3

Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis.

Robertson LE, Huh YO, Butler JJ, Pugh WC, Hirsch-Ginsberg C, Stass S, Kantarjian H, Keating MJ. Robertson LE, et al. Blood. 1992 Jul 1;80(1):29-36. Blood. 1992. PMID: 1377051 Free article.

4

Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia.

Kantarjian HM, Talpaz M, Dhingra K, Estey E, Keating MJ, Ku S, Trujillo J, Huh Y, Stass S, Kurzrock R. Kantarjian HM, et al. Blood. 1991 Nov 1;78(9):2411-8. Blood. 1991. PMID: 1932753 Free article.

5

Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy.

Kantarjian HM, Hirsch-Ginsberg C, Yee G, Huh Y, Freireich EJ, Stass S. Kantarjian HM, et al. Blood. 1990 Aug 15;76(4):808-13. Blood. 1990. PMID: 2166608 Free article.

6

Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.

Cortes JE, Talpaz M, Beran M, O'Brien SM, Rios MB, Stass S, Kantarjian HM. Cortes JE, et al. Cancer. 1995 Jan 15;75(2):464-70. doi: 10.1002/1097-0142(19950115)75:2<464::aid-cncr2820750209>3.0.co;2-e. Cancer. 1995. PMID: 7812917

7

Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy.

Lee MS, Kantarjian H, Talpaz M, Freireich EJ, Deisseroth A, Trujillo JM, Stass SA. Lee MS, et al. Among authors: stass sa. Blood. 1992 Apr 15;79(8):1920-3. Blood. 1992. PMID: 1562719 Free article.

8

RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia.

Hirsch-Ginsberg C, LeMaistre AC, Kantarjian H, Talpaz M, Cork A, Freireich EJ, Trujillo JM, Lee MS, Stass SA. Hirsch-Ginsberg C, et al. Among authors: stass sa. Blood. 1990 Sep 15;76(6):1214-9. Blood. 1990. PMID: 2205309 Free article.

9

Strategy for breakpoint cluster region analysis in chronic myelocytic leukemia in a routine clinical laboratory.

Haber LM, Childs CC, Hirsch-Ginsberg C, Nellis K, Kantarjian HM, Cork A, Trujillo JM, Stass SA. Haber LM, et al. Among authors: stass sa. Am J Clin Pathol. 1990 Dec;94(6):762-7. doi: 10.1093/ajcp/94.6.762. Am J Clin Pathol. 1990. PMID: 2244594

10

Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction.

Lee MS, Chang KS, Freireich EJ, Kantarjian HM, Talpaz M, Trujillo JM, Stass SA. Lee MS, et al. Among authors: stass sa. Blood. 1988 Sep;72(3):893-7. Blood. 1988. PMID: 2458151 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters